Oxford vaccine press info
- Techincal name is ChAdOx1
- ChAdOx1 is based on an adenovirus, which is another virus that causes mild upper respiratory tract infections
- Previously tested on flu, chikungunya, Zika and another coronavirus, Middle East Respiratory Syndrome (MERS).
- Testing for MERS completed a phase I clinical trial. It was safe and induced strong immune responses
- Phase II/III trial will enroll up to 10,260 adults and children across the UK.